Tendon rupture risk linked with GLP-1 use in patients with obesity
“These findings warrant prospective evaluation of potential musculoskeletal adverse effects of GLP-1 agonists,” wrote the authors, led by Jad Lawand, MS, a medical student at the University of Texas Medical Branch.